Life Sciences Legislation And Regulation To Watch In 2015

By Daniel Wilson (January 2, 2015, 2:55 PM EST) -- While some legislative changes may shake up the life sciences sector in 2015, attorneys predict regulations by a U.S. Food and Drug Administration intent on expanding its authority into areas like drug compounding and laboratory developed tests are likely to have a bigger impact.

A difficult legislative environment may make it hard for much life sciences legislation to get traction in the new Congress, but a broad federal regulatory agenda, with the FDA flexing its legal muscle by stepping into areas where it has previously been reluctant to tread will still provide plenty for industry and attorneys to chew on....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!